Skip to content

Harmony TPV Post-Approval Study

Congenital Heart Disease | Tetrology of Fallot | RVOT Anomaly | Pulmonary Regurgitation

The purpose of this study is to characterize the functionality of transcatheter implantation of the Medtronic Harmony Transcatheter Pulmonary Valve (TPV) achieved by real-world implanters.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    0 and up

Critères de participation

Inclusion Criteria:

* Patient eligible to receive the Harmony TPV, meeting the indications for use criteria per current geography-specific device labeling at time of study enrollment
* Patient (or patient's legally authorized representative) is willing to consent to participate in the study

Exclusion Criteria:

* Obstruction of the central veins
* Planned concomitant branch pulmonary artery stenting at time of implant
* Subject is pregnant at time of implant procedure
* Patients with previously treated with an RV-PA conduit or previously implanted bioprosthesis
* A major or progressive non-cardiac disease (e.g. liver failure, renal failure, cancer) that results in a life expectancy of less than one year
* Planned implantation of the Harmony TPV in the left heart
* Echocardiographic evidence of intracardiac mass, thrombus, or vegetation
* Pre-existing prosthetic heart valve or prosthetic ring in any position

Lieu de l'étude

University of Alberta Hospital
University of Alberta Hospital
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Anoop Mathew, MD

Étude parrainée par
Medtronic Cardiovascular
Participants recherchés
Plus d'informations
ID de l'étude: NCT05077774